Stereotaxis Inc STXS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society’s HRX 2026
-
University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program
-
Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates
-
Mobia Medical Appoints Myriam Curet, M.D., to its Board of Directors
-
Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026
-
University of Szeged Pioneers First Robotic Cardiology Program in Hungary
-
Stereotaxis Shares Rise on FDA Clearance for Synchrony
-
Stereotaxis Shares Advance on FDA Approval for Magnetic Catheter
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 100.20M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.25
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 131
- Website
- https://www.stereotaxis.com
Competitors
Valuation
|
Metric
|
STXS
|
ISRG
|
|---|---|---|
Price/Earnings (Normalized) | — | 41.26 |
Price/Book Value | 8.08 | 8.22 |
Price/Sales | 3.25 | 13.76 |
Price/Cash Flow | — | 29.54 |
Price/Earnings
STXS
ISRG
Financial Strength
|
Metric
|
STXS
|
ISRG
|
|---|---|---|
Quick Ratio | 0.91 | 3.64 |
Current Ratio | 1.42 | 4.96 |
Interest Coverage | — | — |
Quick Ratio
STXS
ISRG
Profitability
|
Metric
|
STXS
|
ISRG
|
|---|---|---|
Return on Assets (Normalized) | −27.46% | 18.24% |
Return on Equity (Normalized) | −142.82% | 20.87% |
Return on Invested Capital (Normalized) | −69.55% | 19.08% |
Return on Assets
STXS
ISRG
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|MW<?lkNC | LOCK|rCm | $151B | |||
| Becton Dickinson & Co
BDX
| LOCK|pWK | LOCK|Rv!bz | $52B | |||
| ResMed Inc
RMD
| LOCK|C#tBBqYB | LOCK|!^HQ | $34B | |||
| Alcon Inc
ALC
| LOCK|#?mSpy | LOCK|D^!q | $32B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|Cd?XyyK | LOCK|&!!> | $32B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|$<XX^jmH | LOCK|xl | $27B | |||
| Solventum Corp
SOLV
| LOCK|yyvn!W | LOCK|n^ | $15B | |||
| Baxter International Inc
BAX
| LOCK|!^c | LOCK|Pyq$V | $13B | |||
| Repligen Corp
RGEN
| LOCK|>Mqr%k& | LOCK|p?H!T | $11B | |||
| The Cooper Companies Inc
COO
| LOCK|YD^>K!z | LOCK|@g@d | $11B |
United States